Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Influence of infection on exacerbations of multiple sclerosis.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Women's Issues in Multiple Sclerosis.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Dimethylfumarate induces apoptosis in human mast cells.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Clarity Extension Study
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.

Pages